An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?

Mohit Khera, Trinity Bivalacqua, Irwin Goldstein, Maarten Albersen

Research output: Contribution to journalComment/debatepeer-review

Abstract

Regenerative cell-based therapy for erectile dysfunction is probably safe, and may be functionally beneficial. Currently, phase 2 trials are under way that we hope will provide a better insight into the efficacy of this regenerative therapy.

Original languageEnglish (US)
Pages (from-to)536-538
Number of pages3
JournalEuropean Urology Focus
Volume5
Issue number4
DOIs
StatePublished - Jul 2019

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?'. Together they form a unique fingerprint.

Cite this